pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

613 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1880Endpoints1458Fierce Biotech773BioSpace762BioPharma Dive551raps253onclive165fda recalls
therapy area
allOncology12979Rare Disease3371Immunology3063Cardiology2861Hematology2315Pulmonology2256Vaccines
  • FDA approves treatments for four rare diseases; Pfizer inks $2.6 billion China licensing deal for CAR‑T therapy
    The U.S. Food and Drug Administration has granted approval for drugs targeting four distinct rare diseases, expanding therapeutic options for patients with limited treatment choices. In a separate…
    raps · 1d agoApprovalPositive↗ source
  • Grand Strand Sandwich Co. recalls four Lunch Box sandwich products over Listeria risk
    Grand Strand Sandwich Company Inc. announced a recall of four Lunch Box sandwich items because they may be contaminated with Listeria monocytogenes. The recalled products are the Chicken Sausage B…
    fda recalls · 1d agoCRLNegative
← prev
page 1 of 25
next →
122
fda medwatch116
globenewswire health73
fda press62
1881
Psychiatry & CNS1235
Ophthalmology1140
Endocrinology & Metabolism809
Pain793
Nephrology788
↗ source
  • Drugmakers urged to assess device capabilities and engage regulators early for combo products
    At the AFDO/RAPS Combination Products Summit, a panel of experts advised drugmakers that developing standalone medical devices to be used with their drugs requires careful evaluation of the devices…
    raps · 1d agoRegulatoryNeutral↗ source
  • UK MHRA launches AdvanceGxP to help drugmakers address good practice early
    The Medicines and Healthcare products Regulatory Agency in the United Kingdom has introduced a new service called AdvanceGxP. The initiative is designed to give pharmaceutical companies early guida…
    raps · 1d agoRegulatoryNeutral↗ source
  • FDA issues final guidance on 510(k) ownership transfers, shortening sections and adding Q&A
    The U.S. Food and Drug Administration has released a final guidance that spells out the duties of owners of 510(k) clearances when a product is sold or transferred to another company. The new docu…
    raps · 1d agoRegulatoryNeutral↗ source
  • EU regulators and industry discuss streamlining combination product oversight at summit
    At the AFDO/RAPS Combination Products Summit, a panel of European regulators and industry representatives met to explore ways to simplify the regulatory pathway for combination products in the EU.…
    raps · 3d agoRegulatoryNeutral↗ source
  • FDA releases new manual outlining clinical pharmacology review practices for NDAs and BLAs
    The U.S. Food and Drug Administration’s Office of Translational Sciences and Office of Clinical Pharmacology have issued a new manual of procedures and policies (MAPP).\n\nThe document sets out goo…
    raps · 3d agoRegulatoryNeutral↗ source
  • Larbi Inc. recalls three lots of Yellow Dock Root over possible Salmonella contamination
    Larbi Inc. announced a recall of three lots of its Herb To Body Yellow Dock Root 4-oz product because it may be contaminated with Salmonella. The product was sold nationwide from January to Novemb…
    fda recalls · 2d agoCRLNegative↗ source
  • React Health issues voluntary recall of Luna G3 BPAP devices over data handling error
    React Health (operating as 3B Medical) announced a voluntary correction of certain Luna G3 BPAP System units (model LG3800-30VT) because a data handling issue can produce incorrect therapy pressure…
    fda recalls · 2d agoRegulatoryNegative↗ source
  • Fresh & Ready Foods expands recall to include additional Fresh to You sausage, egg & cheese biscuit sandwiches over Listeria risk
    Fresh & Ready Foods announced an expansion of its November 8 recall, now covering additional Fresh to You sausage, egg & cheese biscuit sandwiches made at its Longview, Texas facility. The move fo…
    fda recalls · 2d agoCRLNegative↗ source
  • FDA to call AI "super intelligence" in all official communications
    The FDA announced that it will replace the term "artificial intelligence" with "super intelligence" in its official materials. The change applies to all correspondence, public communications, webs…
    raps · 3d agoRegulatoryNeutral↗ source
  • Recon: FDA approves Roche’s oral SERD for late-stage breast cancer; Lilly strikes up to $5.9B cancer deal with Stipple Bio
    Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
    raps · 3d ago↗ source
  • FDA rejects ivonescimab for lung cancer; J&J to acquire Ollin Biosciences for up to $3.3B, Senate votes on FDA commissioner
    The FDA has denied the application for ivonescimab as a treatment for lung cancer, halting its development for that indication. Johnson & Johnson announced a deal to purchase Ollin Biosciences, a…
    raps · 4d agoRegulatoryNeutral↗ source
  • Industry groups push for clearer FDA guidance on ANDA and 505(b)(2) filings amid rising patent thickets
    Industry trade groups representing brand‑name and generic manufacturers have asked the FDA to clarify its recent guidance on when a company should file an abbreviated new drug application (ANDA) ve…
    raps · 4d agoRegulatoryNeutral↗ source
  • Experts discuss AI applications and challenges in regulatory conformity assessments
    At a recent RAPS AI in Regulatory Conference in Barcelona, a panel of experts examined how artificial intelligence is being adopted in conformity assessment processes. Participants noted that noti…
    raps · 4d agoRegulatoryNeutral↗ source
  • Naia Inc. recalls Chocolate Banana Bar Sorbetto over undeclared milk, egg and pistachio allergens
    Naia Inc., based in Hercules, California, announced a recall of its Chocolate Banana Bar Sorbetto. The recall applies to bars bearing the code dates "BB:Oct/05/2027", "BB:Oct/06/2027", "BB:Oct/07/…
    fda recalls · 3d agoCRLNegative↗ source
  • Australian regulator seeks feedback on adding unique device IDs to medical device free‑sale certificates
    Australia’s Therapeutic Goods Administration (TGA) announced it is reviewing whether to include unique device identification (UDI) details on certificates of free sale that accompany medical device…
    raps · 4d agoRegulatoryNeutral↗ source
  • ALDI recalls Priano protein tortelloni over possible Clostridium botulinum contamination
    ALDI of Batavia, Illinois announced on November 16, 2026 that it is recalling its Priano Protein Carbonara Tortelloni and Priano Protein Herb & Cheese Tortelloni sold at select stores in Alabama, G…
    fda recalls · 3d agoRegulatoryNegative↗ source
  • Medline recalls all brand beds, rails, mattresses and accessories over fire and entrapment risk
    Medline announced a recall of its entire line of Medline Brand beds, rails, mattresses and related accessories in the United States and Canada. The recall, launched on October 14, 2026, cites a po…
    fda recalls · 6d agoCRLNegative↗ source
  • FDA issues warning letters to three Chinese API makers over record refusals and quality oversight lapses
    The U.S. Food and Drug Administration sent warning letters to three manufacturers of active pharmaceutical ingredients (APIs) based in China. Two of the companies were cited for refusing to provid…
    raps · 7d agoRegulatoryNegative↗ source
  • FDA issues warning letters to three Chinese API makers over record refusals and quality oversight lapses
    The FDA sent warning letters to three active pharmaceutical ingredient manufacturers based in China. Two firms were cited for refusing the agency's requests for records, while the third was found…
    raps · 7d agoRegulatoryNeutral↗ source
  • bioQuad recalls OsteoDenx capsules after discovering undeclared milk, warning allergic consumers
    bioQuad Life Sciences announced a recall of two lots of its OsteoDenx dietary supplement capsules because they contain undeclared milk. The presence of milk, specifically lactoferrin derived from…
    fda recalls · 6d agoCRLNegative↗ source
  • Eros Apothecary recalls Candy Power For Man honey supplement after undisclosed tadalafil found
    Eros Apothecary of Indio, California announced a recall of its Candy Power For Man Organic Honey dietary supplement after FDA testing revealed the presence of undeclared tadalafil. Tadalafil is th…
    fda recalls · 7d agoCRLNegative↗ source
  • FDA pauses voucher program as Eli Lilly's GLP-1 weight-loss drug cleared in China; experts see AI aid for device regulation
    The U.S. Food and Drug Administration announced it is shelving the commissioner's voucher program, effectively pausing the incentive that speeds up review of certain products. Eli Lilly secured ap…
    raps · 8d agoRegulatoryNeutral↗ source
  • EMA seeks industry input on draft guideline for biomarker-guided therapy approvals
    The European Medicines Agency has published a draft guideline that details the information required for approving medicines that use biomarkers to select patients. The agency is opening a public c…
    raps · 8d agoRegulatoryNeutral↗ source